CATEGORY

Paracetamol

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Paracetamol .

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Category Alerts


CATEGORY ALERTS

Income tax department raids Dolo-650 manufacturer micro Lab's office in Bangalore

July 07, 2022
alert level: Medium
CATEGORY ALERTS

Income tax department raids Dolo-650 manufacturer micro Lab's office in Bangalore

July 07, 2022
alert level: Medium
CATEGORY ALERTS

Income tax department raids Dolo-650 manufacturer micro Lab's office in Bangalore

July 07, 2022
alert level: Medium

Become a Beroe LiVE.Ai™ Subscriber to receive proactive alerts on Paracetamol

Schedule a Demo

Paracetamol Market Monitoring Dashboard


Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Schedule a Demo

Paracetamol Industry Benchmarks


Savings Achieved

(in %)

The average annual savings achieved in Paracetamol category is 15.20%

Payment Terms

(in days)

The industry average payment terms in Paracetamol category for the current quarter is 72.0 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length

SLAs/KPIs

Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk

Sanctions

AMEs

Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi

    Paracetamol Market Intelligence

    global market outlook

      • The global market value is around USD 1,190 million in 2022 and is expected to grow at a CAGR of ~5% till 2028
      • The global production of Paracetamol is concentrated in India and China. These two countries occupy about 83.86 percent of the global production. China holds 59.02 percent and India holds 24.84 percent of the total global paracetamol API production, respectively, and their market share is increasing in the recent years.
      • The global production capacity is at 150 kilo tons, and the supply of paracetamol API meets the global demand. There were no major supply disruptions, due to COVID, as Chinese manufacturers resumed production. The US is the biggest consumption market in the world.
      • Anqiu Luan, Farmson, Mallinckrodt, Granules, Zhejiang Kangle, Novacyl SAS and Sri Krishna Pharmaceuticals are the key players in the market
      •  Raw materials account for 60-63 percent of the total cost of production. PAP, PNCB are the major raw materials driving the production cost.

    Paracetamol market report transcript


    Paracetamol Global Market Outlook:

    MARKET OVERVIEW

    Global market value –USD 1,190 million (2022)

    Expected to grow at a CAGR of 5 percent to $1,579 Million by 2028

    MARKET TRENDS:

    Rising demand from pharmaceuticals.

    Increase in the price of API, due to cost of bulk drugs and import surges.

    • The global market value is USD 1,190 million in 2022, and it is expected to grow at a steady rate of 5 percent, due to significant use of paracetamol as an API in large number of OTC drugs

    • The pharmaceutical is the end-use industry for paracetamol. The increasing demand, due to few key factors boosting the market growth of the API, is rising cases of chronic diseases, fever, and increasing population, which have shown rising demand of raw material

    • Due to the panic buying, suppliers are overwhelmed with demand, and raw material shortages are driving prices up. The pandemic has led to a market failure, where high demand meets the limited supply

    Market Overview: Paracetamol

    • The paracetamol market is expected to grow at a significant market share during the forecast period, owing to increasing population and rising dominance of diseases and disorders.

    • The global Paracetamol market was valued at $1,190 million in 2022, and it is expected to grow at a CAGR of 4-5 percent during the forecasted period, 2021–2024

    • The global production of paracetamol is concentrated in India and China. These two countries occupy about 83.86 percent of the global production. China holds 59.02 percent and India holds 24.84 percent of the total global paracetamol production, respectively, and their market share is increasing in the recent years

    • The global production capacity is at 150 kilo tons, and the supply of paracetamol API meets the global demand. There were no major supply disruptions, due to COVID, as Chinese manufacturers resumed production

    • The US is the biggest consumption market in the world

    Cost Structure Analysis for Paracetamol API

    • The raw material cost varies according to the grade of the API & Excipients used and has a major impact on the production cost

    • The labor cost is not so significant, mainly due to the fully automated process for the production process

    • Facility overhead covers such expenses as electricity, cleaning, heat, plant depreciation, and facility support labor (depending on the company) have low impact on the total cost of production

    Porter's Analysis on Paracetamol

    Supplier Power

    • Paracetamol can be manufactured from the basic raw materials, such as phenol and PNCB, or directly from PAP

    • Since most manufacturers are backward integrated, supplier power is minimal

    Barriers to New Entrants

    • Several players in the market have large capacities for APAP. Therefore, the market is well equipped to meet the demand for APAP. This might act as a barrier for new entrants

    Intensity of Rivalry

    • Market is being fragmented, the intensity of rivalry is also high

    • Competition exists among Indian and Chinese manufacturers to supply paracetamol to the developed markets

    Threat of Substitutes

    • There are several analgesics in the market, but APAP has its own market, which it has been holding for several years

    • Therefore, there is no threat of substitutes for this API in the near future

    Buyer Power

    • Although several manufacturers are available in the market choosing a supplier, who has DMF or CEP approved suppliers are crucial

    • Buyer power is moderate, since the number of buyers in the market is also high

    Interesting Reads:

    Discover the world of market intelligence and how it can elevate your business strategies.

    Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.

    Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

    Schedule a Demo Now